James W. Albrecht Jr serves as Executive at INTROGEN THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, James W. Albrecht Jr has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 1, 2007 involved receiving (via award) 32,661 shares valued at $0.
James W. Albrecht Jr currently holds 53,461 shares of INTROGEN THERAPEUTICS INC (INGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James W. Albrecht Jr has been a net neutral trader of INGN stock. They have purchased $0 and sold $0 worth of shares.
James W. Albrecht Jr's most recent insider trade was on Oct 1, 2007, when they sold 32,661 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.39 |
| Discretionary |